Table 1. Baseline Characteristics of Patients With Traditional Insurance Plans vs HDHPs by Matched Cancer and Control Cohorts.
| Characteristic | Cancer cohort | Comparison cohort | ||
|---|---|---|---|---|
| Traditional plan (n = 69 449 [52%]) | HDHP (n = 65 377 [48%]) | Traditional plan (n = 76 128 [56%]) | HDHP (n = 58 698 [44%]) | |
| Age, median (IQR) | 52 (45-58) | 54 (46-59) | 53 (46-59) | 54 (47-59) |
| CCI, median (IQR) | 2 (1-3) | 2 (1-3) | 3 (1-3) | 3 (1-3) |
| Sex, No. (%) | ||||
| Female | 37 722 (54) | 35 850 (55) | 37 730 (50) | 28 889 (49) |
| Male | 31 727 (46) | 29 527 (45) | 38 398 (50) | 29 809 (51) |
| Race and ethnicity, No. (%) | ||||
| Asian | 2523 (4) | 1192 (2) | 2887 (4) | 1119 (2) |
| Black | 5312 (8) | 4651 (7) | 7681 (10) | 5617 (10) |
| Hispanic | 6901 (10) | 4176 (6) | 8143 (11) | 4356 (7) |
| Non-Hispanic White | 54 713 (79) | 55 358 (85) | 57 417 (75) | 47 606 (81) |
| Cancer type | ||||
| Breast | 7982 (12) | 8317 (13) | NA | NA |
| Colorectal | 2551 (4) | 2319 (4) | NA | NA |
| Lung | 966 (1) | 880 (1) | NA | NA |
| Other | 57 590 (83) | 53 861 (82) | NA | NA |
| Insurance product, No. (%) | ||||
| HMO | 17 312 (25) | 3933 (6) | 19 538 (26) | 4010 (7) |
| POS plan | 36 210 (52) | 54 817 (84) | 37 925 (50) | 47 264 (81) |
| EPO | 10 485 (15) | 4039 (6) | 11 366 (15) | 4186 (7) |
| PPO | 3713 (5) | 2434 (4) | 4303 (6) | 3019 (5) |
| Indemnity | 59 (0.08) | 13 (0.02) | 82 (0.1) | 29 (0.05) |
| Other | 1670 (2) | 141 (0.2) | 2914 (4) | 190 (0.3) |
Abbreviations: CCI, Charlson Comorbidity Index; EPO, exclusive provider organization; HDHP, high-deductible health plan; HMO, health maintenance organization; NA, not applicable; POS, point-of-service; PPO, preferred provider organization.